Ain Shams Maternity Hospital
Cairo, Egypt
NCT Number: NCT06117670
The goal of this clinical trial is to test the benefit of using gamma-irradiated amniotic membrane as a graft in surgical repair for women with posterior vaginal wall defects. The main question it aims to answer is:
• Is posterior colporrhaphy using gamma-irradiated amniotic membrane as a graft effective?
Participants will undergo posterior colporrhaphy, which will be modified by adding gamma-irradiated amniotic membrane as a graft during the repair.
Looking for future studies?
Notify Me30 year–60 year
Female
Interventional
Phase 3
Cairo, Egypt
History taking including (personal history, age, menopausal, medical history, and surgical history), as well as symptoms score using Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6) part of the Pelvic Floor Distress Inventory Short Form 20. Also, sexual function will be assessed by Female Sexual Function Index Questionnaire.
Clinical examination: including (general examination, abdominal examination and pelvic examination and POP-Q.
Routine investigations: complete blood count and other preoperative tests as needed.
Posterior colporrhaphy with application of the amniotic membrane graft will be done as follows:
Steps of conventional posterior colporrhaphy:
Postoperative instructions and care:
Follow up of all patients will be done in both groups at 3 and 6 months (symptoms +/- examination as needed).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Posterior colporrhaphy with application of the gamma-irradiated amniotic membrane graft will be done
Time frame: first week postoperative
Prolapse assessment using the prolapse quantification system of the International Continence Society (POP-Q)
Time frame: at 3 months, and at 6 months postoperative
Assessment of symptoms score using Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6) part of the Pelvic Floor Distress Inventory Short Form 20. Scale from 0 to 100, the higher score indicates worse condition.
Time frame: at 3 months, and at 6 months postoperative
to measure sexual satisfaction using female sexual function index questionnaire The Female Sexual Function Index (FSFI) was developed to assess six domains of female sexual function (sexual desire, sexual arousal, lubrication, orgasm, satisfaction, and pain).
Items are scored on a five-point Likert scale with low scores indicating lower levels of sexual functioning. Fifteen items also include a zero score as a sixth response option indicating no sexual activity in the past 4 weeks.
Range: 2 to 36.
Time frame: within 6 months postoperative
Wound infection or wound dehiscence as detected clinically and /or CRP and vaginal swab as needed
Time frame: Intraoperative
occurrence of intraoperative bladder or bowel injury
Ain Shams Maternity Hospital
Other
Gamma-irradiated Amniotic Membrane Graft in Posterior Colporrhaphy. A Pilot One Arm Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06902909
Cystocele, Cystocele, Midline
Seinäjoki, Finland
View Trial DetailsNCT04892108
Defecation Disorder, Digestive System Diseases
Ferrara, Italy
View Trial DetailsNCT07375147
Digestive System Diseases, Gastrointestinal Diseases
Cairo, Al-Manial, Cairo, Egypt, Egypt
View Trial DetailsNCT06252714
Bowel Dysfunction, Digestive System Diseases
Cincinnati, Ohio, United States
View Trial Details